{"id":105356,"date":"2020-04-14T11:36:59","date_gmt":"2020-04-14T18:36:59","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2020\/04\/nanoviricides-inc-progress-on-covid-19-drug-encouraging"},"modified":"2020-04-14T11:36:59","modified_gmt":"2020-04-14T18:36:59","slug":"nanoviricides-inc-progress-on-covid-19-drug-encouraging","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2020\/04\/nanoviricides-inc-progress-on-covid-19-drug-encouraging","title":{"rendered":"NanoViricides, Inc. Progress on COVID-19 Drug Encouraging"},"content":{"rendered":"<p><a class=\"blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/nanoviricides-inc-progress-on-covid-19-drug-encouraging2.jpg\"><\/a><\/p>\n<p>The company\u2019s update on its development of COVID-19 drug candidate is promising.<\/p>\n<p>Vancouver, British Columbia\u2014(Newsfile Corp. \u2014 March 31, 2020) \u2014 NanoViricides, Inc. (NYSE American: NNVC) (the \u201cCompany\u201d) is a nano-biopharmaceutical Company at the development stage, with proprietary and patented drug development work focused on viral diseases. The Company\u2019s research involves the use of a unique nanomedicine technology called nanoviricides \u2014 agents designed to \u201cfool\u201d a virus into attaching to an antiviral nanomachine, in the same way that the virus normally attaches to the receptors on a cell surface, but for the purpose of its neutralization and destruction. NanoViricides was highlighted by SmallCapsDaily for providing an update on its progress to develop a drug that can treat COVID-19, the coronaviral pneumonia disease which is caused by the SARS-CoV-2 virus, aka, 2019-nCoV, also known as the Wuhan coronavirus.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>The company\u2019s update on its development of COVID-19 drug candidate is promising. Vancouver, British Columbia\u2014(Newsfile Corp. \u2014 March 31, 2020) \u2014 NanoViricides, Inc. (NYSE American: NNVC) (the \u201cCompany\u201d) is a nano-biopharmaceutical Company at the development stage, with proprietary and patented drug development work focused on viral diseases. The Company\u2019s research involves the use of a [\u2026]<\/p>\n","protected":false},"author":513,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11,4],"tags":[],"class_list":["post-105356","post","type-post","status-publish","format-standard","hentry","category-biotech-medical","category-nanotechnology"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/105356","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/513"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=105356"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/105356\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=105356"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=105356"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=105356"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}